Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 8, 908 - 909 (2002)
doi:10.1038/nm0902-908b
Resurrecting the resurrection drug
Potter Wickware1
- San Francisco
Over the past decade, the pharmaceutical industry has been steadily increasing its investment in lifestyle drugs (see next page). Although this effort is geared more toward capturing revenue from the developed countries of the West, there can occasionally be a positive outcome for developing nations.
To read this story in full you will need to login or make a payment (see right).
